Comment on: "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance".
作者信息
Harpaz Rave, DuMouchel William, Shah Nigam H
机构信息
Oracle Health Sciences, Bedford, MA, USA,
出版信息
Drug Saf. 2015 Jan;38(1):113-4. doi: 10.1007/s40264-014-0245-9.
Abstract
摘要
相似文献
1
Comment on: "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance".
Drug Saf. 2015 Jan;38(1):113-4. doi: 10.1007/s40264-014-0245-9.
2
Authors' reply to Harpaz et al. comment on: "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance".
Drug Saf. 2015 Jan;38(1):115-6. doi: 10.1007/s40264-014-0246-8.
3
Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.
Drug Saf. 2014 Sep;37(9):655-9. doi: 10.1007/s40264-014-0198-z.
4
Portable automatic text classification for adverse drug reaction detection via multi-corpus training.
J Biomed Inform. 2015 Feb;53:196-207. doi: 10.1016/j.jbi.2014.11.002. Epub 2014 Nov 8.
5
Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
Drug Saf. 2016 Dec;39(12):1189-1195. doi: 10.1007/s40264-016-0463-4.
6
Comment on "Patient Reporting in the EU: Analysis of EudraVigilance Data".
Drug Saf. 2017 Oct;40(10):935-936. doi: 10.1007/s40264-017-0568-4.
7
Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Curr Drug Saf. 2018;13(1):21-25. doi: 10.2174/1574886313666171218123802.
8
Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
Drug Saf. 2017 Oct;40(10):911-921. doi: 10.1007/s40264-017-0563-9.
9
Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344.
10
[Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Ther Umsch. 2015 Dec;72(11-12):669-71. doi: 10.1024/0040-5930/a000735.
引用本文的文献
1
Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug-drug interactions.
Pharmacoepidemiol Drug Saf. 2023 Aug;32(8):832-844. doi: 10.1002/pds.5609. Epub 2023 Mar 26.
2
A reference set of clinically relevant adverse drug-drug interactions.
Sci Data. 2022 Mar 4;9(1):72. doi: 10.1038/s41597-022-01159-y.
3
Finding missed cases of familial hypercholesterolemia in health systems using machine learning.
NPJ Digit Med. 2019 Apr 11;2:23. doi: 10.1038/s41746-019-0101-5. eCollection 2019.
4
Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.
J Am Med Inform Assoc. 2018 Oct 1;25(10):1339-1350. doi: 10.1093/jamia/ocy077.
5
Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature.
BMC Bioinformatics. 2016 Jun 23;17:250. doi: 10.1186/s12859-016-1080-z.
6
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
Drug Saf. 2016 May;39(5):421-32. doi: 10.1007/s40264-016-0392-2.
7
A method for systematic discovery of adverse drug events from clinical notes.
J Am Med Inform Assoc. 2015 Nov;22(6):1196-204. doi: 10.1093/jamia/ocv102. Epub 2015 Jul 31.
本文引用的文献
1
A time-indexed reference standard of adverse drug reactions.
Sci Data. 2014 Nov 11;1:140043. doi: 10.1038/sdata.2014.43.
2
Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.
Drug Saf. 2014 Sep;37(9):655-9. doi: 10.1007/s40264-014-0198-z.
3
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.
Drug Saf. 2014 Aug;37(8):557-67. doi: 10.1007/s40264-014-0189-0.
4
Defining a reference set to support methodological research in drug safety.
Drug Saf. 2013 Oct;36 Suppl 1:S33-47. doi: 10.1007/s40264-013-0097-8.
5
Pharmacovigilance using clinical notes.
Clin Pharmacol Ther. 2013 Jun;93(6):547-55. doi: 10.1038/clpt.2013.47. Epub 2013 Mar 4.
6
Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.
Clin Pharmacol Ther. 2013 Jun;93(6):539-46. doi: 10.1038/clpt.2013.24. Epub 2013 Feb 11.
7
A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
Drug Saf. 2013 Jan;36(1):13-23. doi: 10.1007/s40264-012-0002-x.
Zotero 插件